Attention Deficit Hyperactivity Disorder (ADHD): Epidemiology, Treatment and Prevention

Francisco López-Muñoz (Editor)
Camilo José Cela University, Madrid, Spain

Cecilio Álamo Gónzález (Editor)
University of Alcalá, Madrid, Spain

Series: Neuroscience Research Progress
BISAC: MED057000

Clear

$325.00

Volume 10

Issue 1

Volume 2

Volume 3

Special issue: Resilience in breaking the cycle of children’s environmental health disparities
Edited by I Leslie Rubin, Robert J Geller, Abby Mutic, Benjamin A Gitterman, Nathan Mutic, Wayne Garfinkel, Claire D Coles, Kurt Martinuzzi, and Joav Merrick

eBook

Digitally watermarked, DRM-free.
Immediate eBook download after purchase.

Product price
Additional options total:
Order total:

Quantity:

Details

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder with underlying brain anatomical and functional measures, as well as familial/genetic factors that are major foci of neuropsychiatric research. In recent years, ADHD is one of the neuropsychiatric diseases receiving more attention in scientific literature. During this decade, numerous studies were published on the implementation of diagnostic criteria and assessment tools for clinical research and the social impact of the disease, which continued to discuss genetic and neurobiological aspects.

Psychostimulants are highly effective medications for the treatment of ADHD, and the development of long-acting stimulant formulations has greatly expanded the treatment options for individuals with ADHD. However, despite the established efficacy of the stimulants in ADHD, 10-30% of the adolescent population with ADHD does not respond to stimulants or may not tolerate them due to side effects. The potential for abuse and the stigma of a controlled medication are reasons to consider alternatives to stimulants in children and adolescents with ADHD. Traditionally, ADHD is regarded as a childhood disorder, but it is now clear that ADHD affects both children and adults.

Many adults with ADHD are undiagnosed and untreated. Thus, the negative outcomes reported by most follow-up studies may be a consequence of untreated symptoms. The diagnosis of ADHD is broad and heterogeneous, with multiple causes being of neurological, paediatric and psycho-social nature. With this in mind, it must always be done rigorously by a multidisciplinary team.

This book, from its multidisciplinary and international background (31 authors from four different countries), contributes to relieving readers from uncertainties and worries they may have towards ADHD.
(Imprint: Nova Biomedical)

Preface

Chapter 1
Evolution of International Scientific Production on Attention-Deficit Hyperactivity Disorder: A Bibliometric Analysis of the Last 34 Years
(Francisco López-Muñoz, Francisco J. Povedano, Pilar García-García, Javier Quintero, and Cecilio Álamo, Chair of Genomic Medicine and 2Faculty of Health Sciences, Camilo José Cela University, Madrid, Spain, and others)

Chapter 2
Prevalence of Attention-Deficit/Hyperactivity Disorder
(José Carlos Peláez Álvarez, Laura Rodríguez Moya and Francisco Montañés Rada, Servicio de Psiquiatría, Hospital Universitario Fundación Alcorcón, Madrid, Spain, and others)

Chapter 3
Limitations to a Diagnosis of ADHD
(Klaus Martin Beckmann, School of Medicine, Griffith University, Queensland, Australia)

Chapter 4
Psychological Assessment in ADHD Children
(Mª Poveda Fernández-Martín, Miguel Ángel Pérez-Nieto, Mª José De Dios-Pérez, Department of Psychology, Faculty of Health Sciences, Camilo José Cela University, Madrid, Spain)

Chapter 5
Genomics, Therapeutics and Pharmacogenomics of Attention-Deficit/Hyperactivity Disorder
(Ramón Cacabelos, Clara Torrellas, Iván Tellado, Pablo Cacabelos, Francisco López-Muñoz, Chair of Genomic Medicine, Camilo José Cela University, Madrid, Spain, and others)

Chapter 6
Brain Development in ADHD: A Neuroimaging Perspective
(Victor Pereira, Pilar de Castro-Manglano, Cesar Soutullo, Child & Adolescent Psychiatry Unit, Department of Psychiatry & Medical Psychology, University of Navarra Clinic, Pamplona, Spain)

Chapter 7
Adult Attention-Deficit and Hyperactivity Disorder and Mild Cognitive Impairment: A Case-Control Study
(Ángel B. Golimstok, María J. García-Basalo, María C. Fernández, Nuria E. Campora, Waleska L. Berrios, Juan I. Rojas, Edgardo Cristiano, Department of Neurology, Hospital Italiano de Buenos Aires, Argentina)

Chapter 8
Attention Deficit Hyperactivity Disorder and Traumatic Brain Injury: Connections, Predictors, and Outcomes
(Christopher M. Bonfield and Joseph B. Stoklosa, Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, TN, USA, and others)

Chapter 9
Galenic Formulations of Psychostimulant Drugs
(Pilar García-García, Francisco López-Muñoz, and Cecilio Álamo, Department of Biomedical Sciences (Pharmacology Area), Faculty of Medicine and Health Sciences, University of Alcalá, Madrid, Spain, and others)

Chapter 10
Antidepressant Drugs in Attention Deficit Hyperactivity Disorder
(Silvia E. García-Ramos, Francisco López-Muñoz, Cecilio Álamo and Pilar García-García, Hospital Pharmacy, Principe de Asturias University Hospital, Alcalá de Henares, Madrid, Spain, and others)

Chapter 11
Psychological Treatment in ADHD: Clinical and Educational Perspectives
(Mª José De Dios-Pérez, Miguel Ángel Pérez-Nieto, Mª Poveda Fernández-Martín, Department of Psychology, Faculty of Health Sciences, Camilo José Cela University, Madrid, Spain)

Chapter 12
Is it Possible to Prevent ADHD?
(Javier Quintero, Josefa Pérez-Templado, Patricia Alcindor, ADHD Across Life Spam Program, Psychiatry Department, Universitary Hospital Infanta Leonor, Madrid, Spain, and others)

Index

You have not viewed any product yet.